SOX2-OT and embryonal carcinoma: Moreover, the novel variants of SOX2OT (SOX2OT-S1 and SOX2OT-S2) showed distinct expression patterns and were downregulated during the process of neural differentiation of human embryonal carcinoma stem cells known as the NTERA-2/NT-2 cell line (8,9).